Unigrilin 75mg Injection: Effective Medication for Your Needs

Description:

• Contains active component Eptifibatide.
• Belongs to the class of drugs known as glycoprotein IIb/IIIa inhibitors.
• Used in the treatment of cardiovascular conditions.
• Primarily used in the management of acute coronary syndromes, including unstable angina and non-ST-segment elevation myocardial infarction (NSTEMI).

Uses:

• Coronary angioplasty and stent placement.
• Acute coronary syndrome (ACS).

Therapeutic Effects:

• Binds to platelet glycoprotein IIb/IIIa receptors, obstructing the attachment of fibrinogen and von Willebrand factor.
• Prevents platelet cross-linking, slowing the formation of stable blood clots.

Interaction with Other Drugs:

• Inform the doctor about all medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products.
• Certain medications may interact with Unigrilin 75mg injection, reducing effectiveness or causing undesirable side effects.

Storage:

• Store at room temperature from 20°C to 25°C.
• Keep away from moisture, heat, and light.
• Do not freeze.
• Keep away from children and pets.

Administration:

• Administered through intravenous (IV) infusion by a healthcare provider.
• Patient's vital signs and overall response to the medication require close monitoring by the healthcare professional.

Safety Advices:

• Pregnancy: consult your doctor before using this medication.
• Breastfeeding: consult a doctor before taking this medication.
• Lungs: use cautiously in individuals with severe lung disease.
• Liver: consult your doctor before receiving Unigrilin 75mg injection if you have a history of liver conditions.
• Alcohol: avoid excessive alcohol intake while receiving Unigrilin 75mg injection.
• Driving: use caution if experiencing side effects like dizziness, weakness, or other symptoms.

Side Effects:

• Serious: bleeding, thrombocytopenia, allergic reactions, thrombosis.
• Common: bleeding at injection site, nausea, fever, headache, low blood pressure.

Word of Advice:

• Tell your healthcare provider if you have had bleeding problems, kidney or liver issues, or allergic reactions to medications before.
• If you are planning surgery, tell your provider about this medication.
• Be cautious about medications you take, and don't drink too much alcohol while on this medication.
• Watch for signs of bleeding, like unusual bruising or blood in urine.
• Inform emergency responders that you are on this medication.
• Follow the prescribed dosage closely, and keep emergency contact details handy.

FAQs:

• Q 1. What happens if I miss a dose of Unigrilin 75mg injection?
  • Unigrilin 75mg injection is administered by healthcare professionals during specific medical procedures. If you're concerned about missing a dose, discuss it with your healthcare provider.
• Q 2. Can I eat normally while on Unigrilin 75mg injection?
  • There are generally no specific dietary restrictions while on Unigrilin 75mg injection. However, it's always a good idea to follow a balanced diet and discuss any dietary changes with your healthcare provider.
• Q 3. Is Unigrilin 75mg injection reversible?
  • Unigrilin 75mg injection's effects on platelets are reversible once the medication is stopped. However, the time it takes for platelet function to return to normal can vary.
• Q 4. How often will I be monitored while on Unigrilin 75mg injection?
  • Healthcare providers will closely monitor you while on Unigrilin 75mg injection, especially during procedures and after administration. Regular blood tests and vital sign checks are common.
• Q 5. Can I receive dental procedures while on Unigrilin 75mg injection?
  • Dental procedures can increase bleeding risk. Inform your dentist about Unigrilin 75mg injection use to determine the best approach and timing for dental work.
• Q 6. What should I do if I experience side effects during Unigrilin 75mg injection treatment?
  • If you experience side effects, especially severe ones like significant bleeding or allergic reactions, seek immediate medical attention and inform your healthcare provider.

Fact Box:

• Molecule name: Eptifibatide.
• Therapeutic class: Antiplatelet Agents.
• Pharmacological class: Glycoprotein IIb/IIIa inhibitors.
• Indications:
  • Coronary angioplasty and stent placement.
  • Acute coronary syndrome (ACS).

Tags: Unigrilin, Injection, 75mg, Medication, Pharmaceuticals, HealthCare, Drug